Sinphar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Sinphar Pharmaceutical Co Ltd cash flow reinvestment rate. Sinphar Pharmaceutical Co Ltd (1734) has a Cash Flow Reinvestment Rate of 0.87x as of March 2026, reinvesting NT$101.07 Million (capex NT$101.07 Million ) from operating cash flow of NT$116.42 Million. See 1734 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sinphar Pharmaceutical Co Ltd (2003–2025)
Cash flow reinvestment rate of Sinphar Pharmaceutical Co Ltd from 2003 to 2025. Historical reinvestment intensity for Sinphar Pharmaceutical Co Ltd across 22 annual periods. Explore Sinphar Pharmaceutical Co Ltd (1734) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Sinphar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2003–2025)
Sinphar Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2003 to 2025. Year-by-year capital reinvestment analysis for Sinphar Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Sinphar Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | NT$230.30 Million | NT$584.66 Million | NT$200.94 Million | ▼ -40.6% |
| 2024 | 0.66x | NT$393.33 Million | NT$593.51 Million | NT$256.71 Million | ▼ -69.1% |
| 2023 | 2.14x | NT$635.50 Million | NT$296.37 Million | NT$300.94 Million | ▲ +387.1% |
| 2022 | 0.44x | NT$187.21 Million | NT$425.30 Million | NT$153.44 Million | ▼ -63.1% |
| 2021 | 1.19x | NT$161.77 Million | NT$135.54 Million | NT$161.44 Million | ▲ +7.3% |
| 2020 | 1.11x | NT$162.79 Million | NT$146.39 Million | NT$157.77 Million | ▼ -73.5% |
| 2018 | 4.19x | NT$333.38 Million | NT$79.50 Million | NT$255.69 Million | ▲ +318.9% |
| 2017 | 1.00x | NT$220.09 Million | NT$219.87 Million | NT$171.00 Million | ▼ -63.3% |
| 2016 | 2.73x | NT$238.05 Million | NT$87.18 Million | NT$224.85 Million | ▲ +67.1% |
| 2015 | 1.63x | NT$458.26 Million | NT$280.53 Million | NT$412.04 Million | ▼ -27.5% |
| 2014 | 2.25x | NT$335.00 Million | NT$148.58 Million | NT$294.29 Million | ▼ -9.7% |
| 2013 | 2.50x | NT$741.65 Million | NT$297.09 Million | NT$598.16 Million | ▲ +9.4% |
| 2012 | 2.28x | NT$375.19 Million | NT$164.45 Million | NT$375.19 Million | ▲ +42.3% |
| 2011 | 1.60x | NT$361.69 Million | NT$225.58 Million | NT$361.69 Million | ▲ +43.2% |
| 2010 | 1.12x | NT$292.75 Million | NT$261.49 Million | NT$292.75 Million | ▲ +57.9% |
| 2009 | 0.71x | NT$219.71 Million | NT$309.94 Million | NT$219.71 Million | ▼ -17.6% |
| 2008 | 0.86x | NT$233.25 Million | NT$271.01 Million | NT$233.25 Million | ▼ -63.7% |
| 2007 | 2.37x | NT$414.90 Million | NT$174.85 Million | NT$414.90 Million | ▲ +58.5% |
| 2006 | 1.50x | NT$249.44 Million | NT$166.57 Million | NT$249.44 Million | ▼ -3.1% |
| 2005 | 1.55x | NT$188.76 Million | NT$122.09 Million | NT$188.76 Million | ▲ +68.1% |
| 2004 | 0.92x | NT$160.79 Million | NT$174.81 Million | NT$160.79 Million | ▼ -57.3% |
| 2003 | 2.16x | NT$260.50 Million | NT$120.84 Million | NT$260.50 Million | — |